Fred Hutchinson Cancer Research Center is the third institution to gain an academic bridge program in collaboration with Evotec, with the latest instalment dubbed Lab591.

MCR Therapeutics will develop peptides to stimulate the production of melanin, a pigment which shields humans against ultraviolet rays and skin cancer.

DheeYantra has raised an undisclosed sum from investors including Indian Institute of Management Ahmedabad to build out its NLP software for native Indian vernaculars.

Jim Berbee first joined Warf's board in 2012 after completing a medical residency at University of Wisconsin-Madison Hospital and Clinics.

The vehicle will feature contributions from the Finnish government and the European Investment Fund to support research and science-orientated businesses across Finland.

ChromaCure has spun out of Université libre de Bruxelles with $19.6m in funding to commercialise treatments for cancer based on a new understanding on tumour metastasis.